Your browser doesn't support javascript.
loading
Risk factors for disease progression in idiopathic pulmonary fibrosis.
Raghu, Ganesh; Ley, Brett; Brown, Kevin K; Cottin, Vincent; Gibson, Kevin F; Kaner, Robert J; Lederer, David J; Noble, Paul W; Song, Jin Woo; Wells, Athol U; Whelan, Timothy P; Lynch, David A; Humphries, Stephen M; Moreau, Emmanuel; Goodman, Krista; Patterson, Scott D; Smith, Victoria; Gong, Qi; Sundy, John S; O'Riordan, Thomas G; Martinez, Fernando J.
Afiliación
  • Raghu G; Center for Interstitial Lung Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA graghu@uw.edu.
  • Ley B; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, California, USA.
  • Brown KK; Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado, USA.
  • Cottin V; Center for Rare Pulmonary Diseases, Hospices Civils de Lyon, University of Lyon, UMR754, Lyon, France.
  • Gibson KF; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Kaner RJ; Department of Clinical Medicine and Genetic Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Lederer DJ; Division of Pulmonary, Allergy, and Critical Care, Columbia University Medical Center, New York, New York, USA.
  • Noble PW; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA.
  • Song JW; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Wells AU; Department of Medicine, National Heart & Lung Institute, Royal Brompton Hospital, Imperial College, London, UK.
  • Whelan TP; Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Lynch DA; Department of Radiology, National Jewish Health, Denver, Colorado, USA.
  • Humphries SM; Department of Radiology, National Jewish Health, Denver, Colorado, USA.
  • Moreau E; Research and Development, bioMérieux, Lyon, France.
  • Goodman K; Clinical Research, Gilead Sciences, Inc, Seattle, Washington, USA.
  • Patterson SD; Clinical Research, Gilead Sciences, Inc, Seattle, Washington, USA.
  • Smith V; Clinical Research, Gilead Sciences, Inc, Seattle, Washington, USA.
  • Gong Q; Biostatistics, Gilead Sciences, Inc, Foster City, California, USA.
  • Sundy JS; Clinical Research, Gilead Sciences, Inc, Seattle, Washington, USA.
  • O'Riordan TG; Clinical Research, Gilead Sciences, Inc, Seattle, Washington, USA.
  • Martinez FJ; Department of Medicine, Cornell University, New York City, New York, USA.
Thorax ; 75(1): 78-80, 2020 01.
Article en En | MEDLINE | ID: mdl-31611341
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Pulmonar Idiopática / Anticuerpos Monoclonales Humanizados Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Thorax Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Pulmonar Idiopática / Anticuerpos Monoclonales Humanizados Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Thorax Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido